Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$340K Sell
12,124
-113,725
-90% -$3.03M 0.03% 166
2025
Q4
$3.13M Sell
125,849
-1,020
-0.8% -$25.7K 0.28% 99
2025
Q3
$3.23M Buy
126,869
+169
+0.1% +$4.17K 0.3% 100
2025
Q2
$2.95M Sell
126,700
-2,682
-2% -$62.5K 0.28% 99
2025
Q1
$3.28M Sell
129,382
-11,188
-8% -$293K 0.35% 95
2024
Q4
$3.73M Buy
140,570
+868
+0.6% +$23.5K 0.38% 95
2024
Q3
$4.04M Sell
139,702
-14,749
-10% -$430K 0.4% 93
2024
Q2
$4.32M Buy
154,451
+2,296
+2% +$63.2K 0.26% 114
2024
Q1
$4.22M Buy
152,155
+2,636
+2% +$73.1K 0.25% 117
2023
Q4
$4.3M Sell
149,519
-29,094
-16% -$880K 0.28% 113
2023
Q3
$5.92M Buy
178,613
+3,911
+2% +$138K 0.41% 86
2023
Q2
$6.41M Buy
174,702
+143,326
+457% +$5.58M 0.42% 85
2023
Q1
$1.28M Hold
31,376
0.09% 147
2022
Q4
$1.61M Buy
31,376
+236
+0.8% +$11.3K 0.12% 140
2022
Q3
$1.36M Buy
31,140
+7,510
+32% +$365K 0.11% 141
2022
Q2
$1.24M Sell
23,630
-34,627
-59% -$1.76M 0.09% 143
2022
Q1
$3.02M Sell
58,257
-5,812
-9% -$302K 0.2% 125
2021
Q4
$3.78M Sell
64,069
-116,380
-64% -$5.77M 0.23% 122
2021
Q3
$7.76M Buy
180,449
+1,765
+1% +$78.2K 0.51% 68
2021
Q2
$7M Buy
178,684
+11,680
+7% +$454K 0.46% 82
2021
Q1
$6.05M Buy
167,004
+21,702
+15% +$771K 0.43% 87
2020
Q4
$5.35M Sell
145,302
-5,650
-4% -$207K 0.39% 91
2020
Q3
$5.26M Buy
150,952
+1,237
+0.8% +$43.4K 0.42% 89
2020
Q2
$4.64M Buy
149,715
+2,107
+1% +$71.6K 0.4% 91
2020
Q1
$4.57M Buy
147,608
+11,947
+9% +$407K 0.46% 81
2019
Q4
$5.04M Buy
135,661
+5,519
+4% +$197K 0.42% 86
2019
Q3
$4.44M Buy
130,142
+14,760
+13% +$537K 0.4% 92
2019
Q2
$4.74M Buy
115,382
+6,910
+6% +$274K 0.44% 79
2019
Q1
$4.37M Sell
108,472
-6,509
-6% -$261K 0.44% 82
2018
Q4
$4.76M Sell
114,981
-707
-0.6% -$29.3K 0.53% 60
2018
Q3
$4.84M Sell
115,688
-1,451
-1% -$55.9K 0.48% 69
2018
Q2
$4.03M Sell
117,139
-1,468
-1% -$50.2K 0.41% 79
2018
Q1
$3.99M Buy
118,607
+6,557
+6% +$225K 0.41% 77
2017
Q4
$3.85M Sell
112,050
-3,052
-3% -$104K 0.39% 82
2017
Q3
$3.9M Sell
115,102
-1,466
-1% -$47.1K 0.4% 81
2017
Q2
$3.71M Sell
116,568
-915
-0.8% -$28.9K 0.39% 86
2017
Q1
$3.81M Buy
117,483
+1,407
+1% +$44.4K 0.41% 83
2016
Q4
$3.58M Buy
116,076
+383
+0.3% +$11.7K 0.4% 87
2016
Q3
$3.72M Buy
115,693
+841
+0.7% +$28.1K 0.41% 80
2016
Q2
$3.84M Buy
114,852
+1,523
+1% +$48.6K 0.43% 82
2016
Q1
$3.19M Buy
113,329
+101
+0.1% +$2.88K 0.36% 94
2015
Q4
$3.47M Sell
113,228
-6,634
-6% -$209K 0.41% 83
2015
Q3
$3.57M Buy
119,862
+7,607
+7% +$244K 0.43% 75
2015
Q2
$3.57M Buy
112,255
+2,103
+2% +$68.5K 0.41% 80
2015
Q1
$3.64M Sell
110,152
-3,313
-3% -$105K 0.41% 81
2014
Q4
$3.35M Sell
113,465
-4,896
-4% -$140K 0.36% 89
2014
Q3
$3.32M Buy
118,361
+5,119
+5% +$144K 0.35% 98
2014
Q2
$3.19M Buy
113,242
+12,115
+12% +$345K 0.35% 96
2014
Q1
$3.08M Sell
101,127
-3,289
-3% -$98.1K 0.35% 92
2013
Q4
$3.04M Buy
104,416
+1,823
+2% +$53.1K 0.35% 93
2013
Q3
$2.8M Buy
102,593
+4,296
+4% +$117K 0.34% 93
2013
Q2
$2.61M Buy
+98,297
New +$2.72M 0.33% 98

Other funds holding PFE

MOTCO's PFE Position: Q1 2026 in Review

MOTCO reduced its Pfizer (PFE) stake by 90% in Q1 2026, selling an estimated $3.03M and leaving 12,124 shares worth $340K. The position accounts for 0.03% of the portfolio, ranked #166.

MOTCO first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.76M in Q3 2021. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • MOTCO held 12,124 shares of Pfizer worth $340K as of Q1 2026.
  • MOTCO sold 113,725 Pfizer shares in Q1 2026, an estimated $3.03M.
  • Pfizer made up 0.03% of MOTCO's portfolio in Q1 2026, its #166 holding.
  • MOTCO first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • MOTCO's Pfizer position peaked at $7.76M in Q3 2021.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on MOTCO's 13F filing for Q1 2026, filed 22 Apr 2026.